Tharimmune, Inc. has announced that it will hold a special meeting of stockholders on January 22, 2026. During the meeting, stockholders will be asked to vote on several proposals, including the election of two new directors to the Board, the approval of the issuance of shares of common stock upon the exercise of Strategic Advisor Warrants, the approval of the issuance of shares of common stock upon the exercise of Cryptocurrency Pre-Funded Warrants, an amendment to the 2023 Equity Incentive Plan, and the potential adjournment of the special meeting.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-027966), on December 16, 2025, and is solely responsible for the information contained therein.
Comments